Conclusions: EABI decrease with running and PA diameter decrease with ankle plantar flexion are greater in limbs with than without exertional LE. These measurements may be valuable as noninvasive tests in the workup for functional popliteal entrapment syndrome.
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Contemporary Outcomes and Management of Complex Vascular Surgical Groin Wound Infections
Salim Lala, Salvatore T. Scali, Sarah E. Gray, Kristina A. Giles, Martin R. Back, Javairiah Fatima, Dean Arnaoutakis, Thomas S. Huber. University of Florida, Gainesville, Fla
Objective: Isolated vascular surgical groin wound infections (VS-GWIs) have multiple causes and frequently present as limb-or life-threatening problems, resulting in significant morbidity and mortality. For patients undergoing femoral reconstruction, interposition iliofemoral replacement or extra-anatomic bypass can be used; however, limited data exist comparing different reconstruction strategies or conduit subtypes. Therefore, we sought to describe our experience with management of VS-GWIs and to compare different conduit choices.
Methods: All patients at a single university hospital (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) undergoing treatment of VS-GWI due to primary mycotic or infected pseudoaneurysm secondary to percutaneous intervention or previous prosthetic graft placement were identified. The primary end point was the major adverse limb event (MALE; major amputation, graft occlusion, and open or endovascular reintervention on index limb) rate. Secondary end points included complications and wound healing. Intergroup comparison of outcomes was made between different reconstruction (interposition replacement, extra-anatomic) and conduit choices (autogenous femoral or saphenous vein; antibiotic-impregnated prosthetic graft; cadaveric femoral artery or vein).
Results: There were 158 patients identified (mean age, 65.6 6 12 years; 70% male, 81% hypertension, 52% coronary disease, 37% chronic pulmonary, 16% congestive heart failure), of whom 128 (81%) had unilateral and 30 (19%) had bilateral VS-GWIs. Indications included infected prosthetic bypass/pseudoaneurysm (89%, n ¼ 140; infrainguinal, 116; suprainguinal, 24) and primary mycotic femoral artery complications from percutaneous intervention (11%, n ¼ 18). A majority underwent interposition reconstruction (92%; n ¼ 145); the remaining patients received femoral ligation with or without staged repair (n ¼ 8; 5 with staged reconstruction and 5 without in patients with prior limb amputation) or extra-anatomic bypass (axillofemoral + superficial femoral artery reimplantation, n ¼ 3; transobturator, n ¼ 2). Autogenous conduit was used most commonly (66%; n ¼ 99 of 153), of which 80 (81%) were femoral vein. The remaining patients received cadaveric (19%; n ¼ 28) or prosthetic (14%; n ¼ 21; 13, rifampin-soaked Dacron; 8, polytetrafluoroethylene) grafts. Adjunctive myocutaneous muscle flap was used in 34% (n ¼ 53; sartorius, n ¼ 48; rectus femoris, n ¼ 3; gracilis, n ¼ 2). Overall mean length of stay was 19.3 6 16 days, and 30-day mortality was 6% (n ¼ 9). At time of last follow-up, all living patients had healed femoral wounds; however, 48% (n ¼ 76) experienced reoperation (graft-related endovascular or open Table. Conclusions: VS-GWIs can be safely managed with interposition reconstruction in a majority of patients with acceptable mortality and excellent wound healing rates. However, a significant proportion of patients experience MALEs, with most being bypass related reintervention, highlighting the need for close follow-up and graft surveillance. An autogenous conduit choice was associated with significantly lower rates of reoperation, with femoral vein representing an ideal option in managing complex VS-GWIs.
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Access Objective: Ipsilateral antegrade access (AA) is an alternative access to contralateral retrograde access (RA) to treat infrainguinal occlusive disease. Our goal was to assess whether this technique is associated with higher access site complications.
Methods: The Vascular Quality Initiative database was analyzed from 2010 to 2017 for all infrainguinal peripheral vascular endovascular interventions. We excluded all cases in which there was not one singular access through the common femoral artery. Access type was classified as AA or RA on the basis of the approach. Propensity matching and multivariable analysis were used to determine the effect of AA on access site complications.
Results: There were 45,816 accesses identified (6600 AAs and 39,216 RAs). AA patients were older (70.7 vs 69.1 years), more often were male (66.5% vs 59.1%) and white (79.4% vs 74.6%), and more often had Medicare (58.4% vs 56.6%); less often they were obese (29.3% vs 36.1%), were currently smoking (25.5% vs 28.7%) and diabetic (56% vs 59.8%), had chronic obstructive pulmonary disease (20.7% vs 21.8%), and were ambulatory (69.8% vs 72.5%; P < .05 for all). AA patients were more likely to have a previous inflow stent (9.3% vs 7%), inflow bypass (6.2% vs 1.8%), and contralateral leg bypass (6.3% vs 3.9%; P < .01 for all). There was no difference in preoperative aspirin use (71.6% vs 72.4%); however, clopidogrel use was less in AA (33.9% vs 36.4%), and preoperative anticoagulation use was higher in AA patients (16.9% vs 14.3%; P < .01 for both). AA was more often used in the setting of tissue loss (51.8% vs 45.1%) and for tibial intervention (46.3% vs 35.3%; P < .01 for both). There was no difference between AA and RA in overall hematoma (3% vs 2.7%; P ¼ .21) or hematoma requiring intervention (0.4% vs 0.4%; P ¼ .75) rates. There was no difference in access site occlusion or stenosis (0.2% vs 0.3%; P ¼ .68). These findings were confirmed with 2:1 matching based on preoperative data and type of intervention. Multivariable analysis showed that AA was not associated with any hematoma (odds ratio, 0.87; 95% confidence interval, 0.74-1.02; P ¼ .08) or hematoma requiring intervention (odds ratio, 1.14; 95% confidence interval, 0.74-1.74; P ¼ .56).
Conclusions: AA is safe and is not associated with increased access site complications. This approach remains a viable alternative to traditional RA when it is more feasible.
Author Disclosures: T. W. Cheng: Nothing to disclose; A. Farber: Nothing to disclose; D. W. Jones: Nothing to disclose; S. J. Raulli: Nothing to disclose; D. Rybin: Nothing to disclose; M. L. Schermerhorn: Abbott: Consulting fees (eg, advisory boards), Bolton: Consulting fees (eg, advisory boards), Cook: Consulting fees (eg, advisory boards), Endologix: Consulting fees (eg, advisory boards); J. Siracuse: W. L. Gore: Fee; M. R. Smeds: Nothing to disclose.
VESS23.
Implementation and Results of Practical Grading System for Thoracic Blunt Aortic Injury
Elina Quiroga, Benjamin W. Starnes, Nam Tran, Niten Singh. University of Washington, Seattle, Wash
Objective: We previously proposed a grading system for thoracic blunt aortic injury (TBAI) designed to guide therapy. This study analyzes our outcomes since implementing this system.
Methods: A single-center, retrospective study was conducted of consecutive patients presenting with TBAI between January 2014 and December 2017. The grading system classified injuries into minimal, moderate, or severe on the basis of computed tomography imaging. Clinical end points included timing of operation and mortality. Secondary end points included associated injuries, aortic anatomy, and operative details as well as 30-day follow-up.
Results: During the study period, 87 patients with TBAI were identified. Table I contains demographic and anatomic features. A comparison of our grading system and the Society for Vascular Surgery grading system is seen in Table II . The majority of patients had a moderate injury occurring distal to the left subclavian artery (LSA); 59 patients underwent thoracic endovascular aortic repair (TEVAR), whereas none of the patients with minimal injury (n ¼ 24) required surgical treatment. The mean time to repair was 53 hours (1-191 hours) for moderate injury and 3.6 hours for severe injury (0-7 hours). Operative details are shown in Table II . The average diameter and length of the endograft was 26 mm and 112 cm, respectively, and the LSA was covered in 43% of patients. Intravascular ultrasound to confirm sizing was used in 83% of cases. Most patients (92%) received intravenous heparin during TEVAR, whereas the remainder received only heparin sheath flush because of concern for intracranial hemorrhage. None of the patients underwent LSA revascularization or developed stroke or spinal cord ischemia as a result of the procedure. Operative complications were seen in 6% of patients and included one femoral pseudoaneurysm, one lower extremity compartment syndrome, one type II endoleak requiring LSA embolization, and one intracranial bleed. The 30-day mortality was 7% (n ¼ 1 aorta related). On 30-day postoperative follow-up, computed tomography imaging uniformly revealed positive aortic remodeling, and no secondary aortic intervention was required.
Conclusions: Institutional implementation of our grading system has streamlined treatment of TBAI, and our results confirm the following: patients with minimal injury do not require surgical treatment; patients with moderate injury can safely undergo TEVAR in a semielective manner once they are stable from other injuries; and patients with severe injury require emergent repair. These procedures are expeditious and can be successfully performed percutaneously with a single endograft. Complications are rare, and follow-up reveals excellent remodeling of the aorta, likely resulting in longer interval surveillance requirements for these patients. 
